Peptides DB
Research-centric peptide and protocol reference hub
Study 4 of 20Cerebrolysin literatureeuropepmc · Meta-analysis2026

ABSTRACT NUMBER: ESOC2026A102 META-ANALYSIS: THE EFFECT OF CEREBROLYSIN COMBINED WITH SPEECH THERAPY ON NONFLUENT APHASIA RECOVERY AFTER ISCHEMIC STROKE

Not reported in abstract.

Read at europepmcAdd to compare

Where it sits

this study against the rest of the cerebrolysin corpus
6
Preclinical
6
Observational
0
Open-label
2
Randomised
6
Reviews · this one

Summary and findings

This meta-analysis evaluated the effect of Cerebrolysin combined with speech therapy on recovery from nonfluent aphasia following ischemic stroke. The study included various trials, but specific details on the population, doses, and outcomes were not provided in the abstract. The findings suggest a potential benefit, though the exact numeric results are not detailed.

How much of this paper we could read: title only (0.20). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026

Background

The paper addresses the clinical question of whether Cerebrolysin, a neuropeptide, can enhance recovery from nonfluent aphasia in patients who have suffered an ischemic stroke. Prior studies have suggested potential benefits of speech therapy in aphasia recovery, but the role of Cerebrolysin in this context remains unclear. This meta-analysis aims to clarify the combined effect of these interventions.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.

Limitations

  • Not reported in abstract.

Elsewhere in the Cerebrolysin corpus

AOptimized seasonal influenza mRNA vaccine compositions demonstrate safety and enhanced immunogenicity in a phase 2 study.Human vaccines & immunotherapeutics · 2026 · Not reported in abstract.HumanCTranscriptomic analysis reveals and validates lipid raft-associated biomarkers and functional networks in Alzheimer's disease.IBRO neuroscience reports · 2026 · Eight key biomarkers showed strong diagnostic performance across datasets.In vitroCNear-IR laser-induced and spontaneous conformational transformations in monomers of 9-methylhypoxanthine.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2026 · Not reported in abstract.In vitroC24-Epibrassinolide enhances aluminum tolerance in tobacco through Ca²⁺-dependent signaling, antioxidant regulation, and metal homeostasis.Plant signaling & behavior · 2026 · Not reported in abstract.In vitroDUnleashing the power of DNA-encoded libraries for challenging targets in drug discovery.Pharmaceutical science advances · 2026reviewDInfluence of sound vibrations on plant holobionts: physiological pathways linking root function and rhizospheric microbial interactions.Plant signaling & behavior · 2026review